JimmyChung (Talk | contribs) |
|||
Line 18: | Line 18: | ||
<body> | <body> | ||
− | <div class="column full_size"> | + | <div class="column full_size" style="width:1200px;margin-left:12%"> |
<h2>Parts</h2> | <h2>Parts</h2> | ||
<p><b>Previous Parts 4-HT Dependent Intein - </b><a href="http://parts.igem.org/Part:BBa_J32009">http://parts.igem.org/Part:BBa_J32009</a></p> | <p><b>Previous Parts 4-HT Dependent Intein - </b><a href="http://parts.igem.org/Part:BBa_J32009">http://parts.igem.org/Part:BBa_J32009</a></p> | ||
Line 26: | Line 26: | ||
</div> | </div> | ||
− | <div class="column full_size"> | + | <div class="column full_size" style="width:1200px;margin-left:12%"> |
<h3>Part Table </h3> | <h3>Part Table </h3> | ||
Line 37: | Line 37: | ||
<html> | <html> | ||
</div> | </div> | ||
− | + | <footer style="background-color: #212121;height:90px "> | |
+ | <div class="container"> | ||
+ | <div class="row"> | ||
+ | <div class="col-md-4"> | ||
+ | <ul class="list-inline quicklinks"> | ||
+ | <li><a href="https://igem.org/Main_Page" style="color:white; font-size:16pt">iGEM Headquarters</a> | ||
+ | </li> | ||
+ | </ul> | ||
+ | </div> | ||
+ | <div class="col-md-4"> | ||
+ | <ul class="list-inline social-buttons" style="margin-left:20%"> | ||
+ | <li><a href="https://twitter.com/iGEMQueens"style=" display: block; | ||
+ | background-color: #fff; | ||
+ | height: 40px; | ||
+ | width: 40px; | ||
+ | border-radius: 100%; | ||
+ | font-size: 20px; | ||
+ | line-height: 40px; | ||
+ | color: #000; | ||
+ | outline: 0; | ||
+ | -webkit-transition: all .3s; | ||
+ | -moz-transition: all .3s; | ||
+ | transition: all .3;"><i class="fa fa-twitter"style="color:black; font-family:FontAwesome;margin-left:10.75px;"></i></a> | ||
+ | </li> | ||
+ | <li><a href="https://www.facebook.com/iGEMQueens/?fref=ts"style=" display: block; | ||
+ | background-color: #fff; | ||
+ | height: 40px; | ||
+ | width: 40px; | ||
+ | border-radius: 100%; | ||
+ | font-size: 20px; | ||
+ | line-height: 40px; | ||
+ | color: #000; | ||
+ | outline: 0; | ||
+ | -webkit-transition: all .3s; | ||
+ | -moz-transition: all .3s; | ||
+ | transition: all .3;"><i class="fa fa-facebook"style="color:black;font-family:FontAwesome;margin-left:10.75px;"></i></a> | ||
+ | </li> | ||
+ | <li><a href="mailto:director@qgemteam.com" style=" display: block; | ||
+ | background-color: #fff; | ||
+ | height: 40px; | ||
+ | width: 40px; | ||
+ | border-radius: 100%; | ||
+ | font-size: 20px; | ||
+ | line-height: 40px; | ||
+ | color: #000; | ||
+ | outline: 0; | ||
+ | -webkit-transition: all .3s; | ||
+ | -moz-transition: all .3s; | ||
+ | transition: all .3;"><i class="fa fa-envelope"style="color:black;font-family:FontAwesome;margin-left:10.75px;"></i></a> | ||
+ | </li> | ||
+ | <li><a href="https://www.linkedin.com/company/1633448?trk=tyah&trkInfo=clickedVertical%3Acompany%2CclickedEntityId%3A1633448%2Cidx%3A1-1-1%2CtarId%3A1464110668532%2Ctas%3Aqgem" style=" display: block; | ||
+ | background-color: #fff; | ||
+ | height: 40px; | ||
+ | width: 40px; | ||
+ | border-radius: 100%; | ||
+ | font-size: 20px; | ||
+ | line-height: 40px; | ||
+ | color: #000; | ||
+ | outline: 0; | ||
+ | -webkit-transition: all .3s; | ||
+ | -moz-transition: all .3s; | ||
+ | transition: all .3;"><i class="fa fa-linkedin"style="color:black; font-family:FontAwesome;margin-left:10.75px;"></i></a> | ||
+ | </li> | ||
+ | </ul> | ||
+ | </div> | ||
+ | <div class="col-md-4"> | ||
+ | <ul class="list-inline quicklinks" style="color: white;font-size:16pt;"> | ||
+ | <li><a href="http://www.queensu.ca/" style="color:white;margin-left:100px;">Queen's University</a> | ||
+ | </li> | ||
+ | </ul> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </footer> | ||
</body> | </body> | ||
</html> | </html> |
Revision as of 18:55, 18 September 2018
Parts
Previous Parts 4-HT Dependent Intein - http://parts.igem.org/Part:BBa_J32009
The 4-hydroxytamoxifen (4-HT) dependent intein splices in the presence of 4-HT in Yeast which allows for the ability to control the production of a desired engineered protein in a dose-dependent manner.
Part Table
Please include a table of all the parts your team has made during your project on this page. Remember part characterization and measurement data must go on your team part pages on the Registry.
<groupparts>iGEM18 Queens_Canada</groupparts>